Proteins.1 develops ultra-sensitive protein detection technology for biomarker research, liquid biopsy, and next-generation diagnostics.
Location: Finland
Total raised: $5.5M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 24.04.2026 | Pre-Seed | $5.5M | Lifeline V... |
Mentions in press and media 5
| Date | Title | Description |
| 27.04.2026 | Proteins.1 Reinvents Diagnostics: Unlocks 1,000x Sensitivity for Early Disease Detection | Proteins.1 secured €4.7M in pre-seed funding. This Finnish deep-tech firm revolutionizes diagnostics. Their patented platform amplifies single protein molecules. It offers PCR-like sensitivity for proteins. No prior equivalent existed for d... |
| 24.04.2026 | Proteins.1 Launches With €4.7 Million To Bring PCR-Like Amplification To Protein Diagnostics | Proteins.1, a VTT-originated Finnish deep-tech startup, has launched with €4.7 million in pre-seed funding to commercialize a single-molecule protein amplification technology it says could enable disease detection up to 1,000 times more sen... |
| 20.04.2026 | Proteins.1 Raises $4.7M in Pre-Seed Funding | Proteins.1, an Espoo, Finland-based deep-tech diagnostics company, raised $4.7M in Pre-Seed funding. The round was led by Lifeline Ventures and Cloudberry Ventures, with participation from VTT and Business Finland. The company intends to us... |
| 16.04.2026 | VTT-originated startup Proteins.1 launches to bring PCR-like amplification and simplicity to omics | VTT-originated startup Proteins.1 launches to bring PCR-like amplification and simplicity to omics Thu, Apr 16, 2026 08:00 CET Report this content Press release 16 April 2026 New Finnish deep-tech company aims to make ultra-early disease de... |
| - | Proteins.1 | “Proteins.1 develops ultra-sensitive protein detection technology for biomarker research, liquid biopsy, and next-generation diagnostics.” |